Star Combo Pharma Limited announced a business update for the quarter ended 30 September 2020. For the quarter, the company continues to progress its contract manufacturing (OEM) expansion strategy, delivering a revenue performance. The company's facility expansion and plant upgrade project commenced in September and this project is on-track and has progressed within expected timelines. Subsequent to the quarter, Star Combo won a new manufacturing contract with Chemist Warehouse. While this contract is not of a significant size in the initial stages, it is expected to make a growing financial contribution to the company's revenue from H2 FY21 and beyond. It is also indicative of the momentum Star Combo is having in selling its enhanced contract manufacturing offering to an expanded customer base.